Opus Genetics, Inc. SEC filings IRD
Opus Genetics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 17, 2005. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 7, 2026 | — |
| 424B2 | Prospectus | Jun 17, 2026 | — |
| S-3 | Shelf registration | Jun 5, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| S-3/A | Filing | Apr 21, 2026 | — |
| S-3 | Shelf registration | Mar 13, 2026 | — |
| S-8 | Employee stock plan registration | Jan 22, 2026 | — |
| FWP | Free writing prospectus | Nov 6, 2025 | — |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| S-8 | Employee stock plan registration | Sep 26, 2025 | — |
| S-8 | Employee stock plan registration | Sep 10, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| S-3/A | Filing | Apr 8, 2025 | — |
| 424B5 | Prospectus supplement | Apr 4, 2025 | — |
| 424B5 | Prospectus supplement | Mar 24, 2025 | — |
| FWP | Free writing prospectus | Mar 21, 2025 | — |
| FWP | Free writing prospectus | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| S-3 | Shelf registration | Feb 18, 2025 | — |
| 424B5 | Prospectus supplement | Jan 13, 2025 | — |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| S-8 | Employee stock plan registration | Jan 11, 2024 | — |
| S-3 | Shelf registration | Jan 10, 2024 | — |
| S-8 | Employee stock plan registration | Nov 21, 2023 | — |
| 424B5 | Prospectus supplement | Aug 14, 2023 | — |
| S-8 | Employee stock plan registration | Apr 5, 2023 | — |
| S-8 | Employee stock plan registration | Apr 5, 2022 | — |
| 424B5 | Prospectus supplement | Jun 7, 2021 | — |
| S-8 | Employee stock plan registration | Mar 31, 2021 | — |
| 424B5 | Prospectus supplement | Mar 11, 2021 | — |
| 424B4 | Prospectus | Feb 17, 2021 | — |
| S-3/A | Filing | Feb 11, 2021 | — |
| S-3 | Shelf registration | Feb 4, 2021 | — |
| S-8 | Employee stock plan registration | Nov 9, 2020 | — |
| 424B3 | Prospectus | Oct 2, 2020 | — |
| S-4/A | Filing | Sep 30, 2020 | — |
| S-4/A | Filing | Sep 16, 2020 | — |
| S-4/A | Filing | Aug 27, 2020 | — |
| S-4 | Registration for a merger or exchange | Jul 6, 2020 | — |
| 424B5 | Prospectus supplement | Jan 24, 2019 | — |
| 424B5 | Prospectus supplement | Jan 22, 2019 | — |
| 424B5 | Prospectus supplement | Oct 18, 2018 | — |
| 424B5 | Prospectus supplement | Oct 17, 2017 | — |
| S-3/A | Filing | Jul 6, 2017 | — |
| S-3/A | S-3a | Jun 23, 2017 | — |
| 424B5 | Prospectus supplement | Jun 8, 2017 | — |
| S-3 | Shelf registration | May 26, 2017 | — |
| S-8 | Employee stock plan registration | May 3, 2017 | — |
| 424B5 | Prospectus supplement | Sep 15, 2016 | — |
| 424B5 | Prospectus supplement | Mar 1, 2016 | — |
| 424B5 | Prospectus supplement | Nov 10, 2015 | — |
| 424B5 | Prospectus supplement | Nov 6, 2015 | — |
| 424B5 | Prospectus supplement | Mar 16, 2015 | — |
| S-3/A | Rexahn pharmaceuticals, inc s-3/a 6-18-2014 | Jun 18, 2014 | — |
| S-3 | Shelf registration | May 23, 2014 | — |
| 424B5 | Prospectus supplement | Jan 17, 2014 | — |
| 424B5 | Prospectus supplement | Jan 17, 2014 | — |
| 424B5 | Prospectus supplement | Oct 15, 2013 | — |
| 424B5 | Prospectus supplement | Jul 24, 2013 | — |
| S-8 | Employee stock plan registration | Jun 11, 2013 | — |
| 424B5 | Prospectus supplement | Nov 30, 2012 | — |
| 424B5 | Prospectus supplement | Nov 29, 2012 | — |
| S-3 | Shelf registration | Jun 22, 2011 | — |
| 424B5 | Prospectus supplement | Mar 30, 2011 | — |
| 424B5 | Prospectus supplement | Jun 28, 2010 | — |
| 424B5 | Prospectus supplement | Oct 21, 2009 | — |
| FWP | Free writing prospectus | Jun 5, 2009 | — |
| 424B3 | Prospectus | May 20, 2009 | — |
| S-3 | Shelf registration | Jul 30, 2008 | — |
| S-8 | Employee stock plan registration | Oct 28, 2005 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1228627
- Former names
- Ocuphire Pharma, Inc. (until Oct 22, 2024); REXAHN PHARMACEUTICALS, INC. (until Nov 9, 2020); CORPORATE ROAD SHOW DOT COM INC (until Apr 29, 2005); FERRARO FRANK (until Apr 29, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.